JPRN-UMIN000008571已完成2 期
Phase II study of weekly fractionated hepatic arterial infusion of Sorafenib and Cisplatin for advanced hepatocellular carcinoma. - Phase II study of weekly fractionated hepatic arterial infusion of Sorafenib and CDDP for advanced
Kansai Medical University Hirakata Hospital0 个研究点目标入组 33 人开始时间: 2012年7月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Presence of metastasis 2.Presence of hepatic encephalopathy 3.Patients with active bacterial infection 4.Patients having blood vessel abnormality that difficult to insert hepatic arterial infusion port 5.Patients having severe disease 6.Patients losing of control over bowel movements 7.Patients with double cance 8.During pregnancy or breast-feeding woman 9.Contraindication of sorafenib or cisplatin
研究者
相似试验
进行中（未招募）
不适用
Phase II study to evaluate hepatic function and clinical aspects in patients with severe hepatic cirrhosis treated with multiple cycle of stem cells mobilisation by G-CSF administration. - NDHepatic cirrhosis with severe liver dysfunctionMedDRA version: 6.1Level: PTClassification code 10019663EUCTR2007-001705-21-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
招募中
2 期
Cohort phase 2 study of hepatic arterial chemotherapy with cisplatin and 5-FU, and sorafenib in patients with advanced unresectable hepatocellular carcinomaunresectable advanced hepatocellular carcinomaJPRN-UMIN000004022Kurume University, School of Medicine, Division of Gastroenterology80
已完成
2 期
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisJPRN-UMIN000000488Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital25
已完成
2 期
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic MalignancyHepatic CancerNCT00587067Memorial Sloan Kettering Cancer Center34
招募中
2 期
MASCARPONE studyJPRN-jRCTs031220099Ikeda Masafumi50